These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 15531516

  • 1. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation.
    Tarkun I, Arslan BC, Cantürk Z, Türemen E, Sahin T, Duman C.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5592-6. PubMed ID: 15531516
    [Abstract] [Full Text] [Related]

  • 2. Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome.
    Tarkun I, Cetinarslan B, Türemen E, Sahin T, Cantürk Z, Komsuoglu B.
    Eur J Endocrinol; 2005 Jul; 153(1):115-21. PubMed ID: 15994753
    [Abstract] [Full Text] [Related]

  • 3. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 4. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 5. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
    Kravariti M, Naka KK, Kalantaridou SN, Kazakos N, Katsouras CS, Makrigiannakis A, Paraskevaidis EA, Chrousos GP, Tsatsoulis A, Michalis LK.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
    [Abstract] [Full Text] [Related]

  • 6. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Alexandraki K, Piperi C, Protogerou A, Katsikis I, Paterakis T, Lekakis J, Panidis D.
    Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
    [Abstract] [Full Text] [Related]

  • 7. Low grade chronic inflammation in women with polycystic ovarian syndrome.
    Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2453-5. PubMed ID: 11397838
    [Abstract] [Full Text] [Related]

  • 8. Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome.
    Ruan X, Dai Y.
    Med Princ Pract; 2009 Jun; 18(2):118-22. PubMed ID: 19204430
    [Abstract] [Full Text] [Related]

  • 9. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.
    Mather KJ, Verma S, Corenblum B, Anderson TJ.
    J Clin Endocrinol Metab; 2000 May; 85(5):1851-6. PubMed ID: 10843164
    [Abstract] [Full Text] [Related]

  • 10. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF.
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [Abstract] [Full Text] [Related]

  • 11. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
    Hu W, Qiao J, Yang Y, Wang L, Li R.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
    [Abstract] [Full Text] [Related]

  • 12. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
    El-Mesallamy HO, Abd El-Razek RS, El-Refaie TA.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):178-82. PubMed ID: 23434327
    [Abstract] [Full Text] [Related]

  • 13. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [Abstract] [Full Text] [Related]

  • 14. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
    Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB, Lobo RA.
    Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
    [Abstract] [Full Text] [Related]

  • 15. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S, Bahceci M, Tuzcu A, Kale E, Gökalp D.
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [Abstract] [Full Text] [Related]

  • 16. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
    Aydogdu A, Tasci I, Tapan S, Basaran Y, Aydogan U, Meric C, Sonmez A, Aydogdu S, Akbulut H, Taslipinar A, Uckaya G, Azal O.
    Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
    [Abstract] [Full Text] [Related]

  • 17. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C, McGrath BP, Teede HJ.
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [Abstract] [Full Text] [Related]

  • 18. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G, Steinberg HO, Shepard MK, Hook G, Baron AD.
    J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
    [Abstract] [Full Text] [Related]

  • 19. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
    Wijeyaratne CN, Nirantharakumar K, Balen AH, Barth JH, Sheriff R, Belchetz PE.
    Clin Endocrinol (Oxf); 2004 May; 60(5):560-7. PubMed ID: 15104558
    [Abstract] [Full Text] [Related]

  • 20. Retinol-binding protein 4, as a negative acute-phase reactant in polycystic ovary syndrome.
    Güdücü N, Görmüş U, Telatar B, Dünde I.
    Minerva Endocrinol; 2014 Dec; 39(4):299-304. PubMed ID: 25371056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.